Physician

Byron Scott Ladd, M.D.

According to 2025 Medicare claims, Byron Ladd, M.D. (NPI: 1619086634) practices ophthalmology in the Richmond, VA market, with the plurality of this provider's patient population coming from Chesterfield, VA. This provider's primary affiliated billing organization is EYE SURGEONS OF RICHMOND, INC. (NPI: 1669480448; TIN: 541119248) and primary practice location at 23230-1701.

Ladd's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,423 traditional Medicare patients, billed 53,348 HCPCS/CPT codes, and received $5,748,590 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 387 prescription claims across 143 beneficiaries totaling $41,207 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 23 records totaling $841. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,209,165 to $5,748,590. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $29,884 and ending at $41,207. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.9M$5.7M2015 Medicare payment: $3,209,165 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,969,126 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,207,151 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,400,127 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,699,130 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,818,386 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,390,608 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,112,401 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,916,701 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,748,590 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,27414,544$3,209,165
20161,43013,078$2,969,126
20171,35013,420$3,207,151
20181,28114,927$3,400,127
20191,51416,945$3,699,130
20201,40515,487$3,818,386
20211,55516,813$4,390,608
20221,51219,518$4,112,401
20231,54535,683$3,916,701
20241,42353,348$5,748,590

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$69K$139K2015 Drug cost: $29,884 (USD; Tot_Drug_Cst)2016 Drug cost: $41,794 (USD; Tot_Drug_Cst)2017 Drug cost: $37,435 (USD; Tot_Drug_Cst)2018 Drug cost: $36,099 (USD; Tot_Drug_Cst)2019 Drug cost: $138,707 (USD; Tot_Drug_Cst)2020 Drug cost: $36,510 (USD; Tot_Drug_Cst)2021 Drug cost: $46,871 (USD; Tot_Drug_Cst)2022 Drug cost: $47,030 (USD; Tot_Drug_Cst)2023 Drug cost: $46,826 (USD; Tot_Drug_Cst)2024 Drug cost: $41,207 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015104326$29,884
201697292$41,794
201784207$37,435
201888244$36,099
201997258$138,707
202082241$36,510
2021146386$46,871
2022127347$47,030
2023115326$46,826
2024143387$41,207

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye4852,605$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more470666$96
92014Established patient complete exam of visual system1,0211,257$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more412600$66
92134Imaging of retina1,2773,235$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium482,231$21,588
Bromfenac SodiumBromfenac Sodium401,497$6,594
Prednisolone AcetatePrednisolone Acetate1094,254$4,379
Timolol MaleateTimolol Maleate161,170$1,078
OfloxacinOfloxacin561,101$516

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$841Notal Vision, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Byron Scott Ladd, M.D.?

Tedicare shows public-source Medicare data for Byron Scott Ladd, M.D. (NPI 1619086634), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Byron Scott Ladd, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Byron Scott Ladd, M.D.?

Byron Scott Ladd, M.D. is linked to EYE SURGEONS OF RICHMOND, INC. (billing NPI 1669480448) in the available physician profile data.

Does Byron Scott Ladd, M.D. have Open Payments data?

Byron Scott Ladd, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.